Brief: Alkermes Appoints Caroline Loew As Chief Executive Officer Designate Of Mural Oncology PLC
01/06/2023 21:03
June 1 (Reuters) - Alkermes Plc ALKS.O :
* ALKERMES APPOINTS CAROLINE J. LOEW, PH.D., AS CHIEF
EXECUTIVE
OFFICER DESIGNATE OF MURAL ONCOLOGY PLC
* ALKERMES PLC- LOEW TO ASSUME NEW LEADERSHIP ROLE UPON
COMPLETION
OF PLANNED SEPARATION OF ALKERMES' ONCOLOGY BUSINESS
* ALKERMES PLC- PLANNED SEPARATION REMAINS ON TRACK TO BE
COMPLETED IN SECOND HALF OF 2023
Source text for Eikon: ID:nPrevsXkRa
Further company coverage: ALKS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkermes
See all newsBrief: Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study Of Alixorexton In Adults With Narcolepsy Type 2 At Sleep 2026
Brief: Alkermes Announces Positive Topline Results From Revitalyz Phase 3 Study Evaluating Lumryz
Brief: Alkermes Announces Effectiveness Of Mural Oncology Form 10 Registration Statement
Alkermes Plc reports results for the quarter ended in September - Earnings Summary
Brief: Alkermes Q3 Net Income USD 47.8 Million